发明名称 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND
摘要 <p>The present invention provides a novel immunity induction method, particularly, a method of simultaneously inducing activation of NKT cells and T-cell immune responses. To be more precise, the present invention provides a target antigen and CD1d co-expressing cell, and a preparation and identification method thereof; a target antigen and CD1d co-expressing cell capable of activating immunity to the target antigen, and a preparation method thereof; an immunoinducer to a target antigen or a pharmaceutical agent, which contains a target antigen and CD1d co-expressing cell capable of activating immunity to the target antigen; a target antigen and CD1d co-expressing vector; a kit containing an expression vector and/or a CD1d ligand; and the like.</p>
申请公布号 EP1990410(A1) 申请公布日期 2008.11.12
申请号 EP20070714709 申请日期 2007.02.21
申请人 RIKEN 发明人 FUJII, SHIN-ICHIRO;SHIMIZU, KANAKO
分类号 C12N15/00;A61K35/12;A61K35/14;A61K39/00;A61K39/02;A61K39/12;A61P31/00;A61P31/12;A61P35/00;A61P37/04;C12N5/10;C12N15/09;C12Q1/02 主分类号 C12N15/00
代理机构 代理人
主权项
地址